A study for a 34 year old woman who takes Vimpat - from FDA reports


Summary

659 females aged 34 (±5) who take the same drug are studied. This is a personalized study for a 34 year old female patient who has Epilepsy. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>


On Jan, 07, 2018

659 females aged 34 (±5) who take Vimpat are studied.


Number of reports submitted per year:

Vimpat for a 34-year old woman.

Information of the patient in this study:

  • Age: 34
  • Gender: female
  • Conditions: Epilepsy
  • Drugs taken:
    • Vimpat (lacosamide)

eHealthMe real world results:

Comparison with this patient's adverse outcomes:

  • Migraine: 8 (1.21% of females aged 34 (±5) who take the drug)

As an adverse outcome could be a symptom of a condition, additional studies are listed to help identify the cause: for example, regardless of which drug is taken, how many female HBP patients aged 50 (±5) have nausea

As an adverse outcome could be a side effect of a drug, additional studies are listed to help identify the cause: for example, how many female Aspirin users aged 50 (±5) have nausea

Most common side effects over time

< 1 month:
  • convulsion
  • dizziness
  • agranulocytosis
  • nausea
  • fatigue
  • drowsiness
  • headache
  • nausea and vomiting
  • stress and anxiety
  • tremor
1 - 6 months:
  • dizziness
  • convulsion
  • nausea
  • birth control
  • headache
  • fatigue
  • status epilepticus
  • nausea and vomiting
  • drug ineffective
  • appetite - decreased
6 - 12 months:
  • birth control
  • convulsion
  • road traffic accident
  • concussion
  • agranulocytosis
  • overdose
  • dizziness
  • suicidal ideation
  • nausea and vomiting
  • drug ineffective
1 - 2 years:
  • head injury
  • fall
  • convulsion
  • feeling drunk
  • birth control
  • abortion spontaneous
  • memory loss
  • lipoma
  • implant site extravasation
  • overdose
2 - 5 years:
  • drowsiness
  • consciousness - decreased
  • nausea and vomiting
  • overdose
  • depression
  • stroke
  • abortion induced
  • sudden unexplained death in epilepsy
  • blood sodium decreased
  • birth control
5 - 10 years:
  • dizziness
  • international normalised ratio increased
  • cardiac arrest
  • eating disorder
10+ years:
n/a
not specified:
  • convulsion
  • diplopia
  • balance disorder
  • dizziness
  • birth control
  • neurotoxicity
  • drug ineffective
  • fatigue
  • gait disturbance
  • overdose

Top conditions involved for these people *:

  • Convulsion (87 people, 13.20%)
  • Partial Seizures (33 people, 5.01%)
  • Depression (23 people, 3.49%)
  • Pain (16 people, 2.43%)
  • Migraine (15 people, 2.28%)

Top co-used drugs for these people *:

  • Keppra (153 people, 23.22%)
  • Topiramate (82 people, 12.44%)
  • Lamictal (70 people, 10.62%)
  • Phenytoin (57 people, 8.65%)
  • Lamotrigine (50 people, 7.59%)

* Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the conditions?

What are the symtoms?

Could your drugs cause:

Could your conditions cause:

Related studies:

Can you answer these questions?

More questions for: Vimpat, Migraine Epilepsy

You may be interested in these posts

More posts for: Vimpat, Migraine Epilepsy